Actively Recruiting
Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.
Led by Meyer Children's Hospital IRCCS · Updated on 2025-03-06
90
Participants Needed
4
Research Sites
92 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The proposed study is part of a PNRR 2022 project (call "Non-Communicable Chronic Diseases (NCDs) with high impact on healthcare and social assistance systems," currently awaiting funding response) and represents the continuation of an observational clinical study named TRANSMIC, approved by the pediatric ethics committee of the Tuscany region. TRANSMIC was an integral part of a European research project within the joint programming initiative (JPI), under the HDHL-INTIMIC theme: "A Healthy Diet for a Healthy Life," aimed at understanding the cause-effect relationships between diet, gut microbiome, and human health. Understanding the role of diet in inflammatory bowel diseases (IBD) and exploring its role in autoimmune inflammatory conditions with joint manifestations, such as JIA, provides additional insights into the development, progression, and management of these conditions, opening new horizons for the use of dietary treatments in preventing these inflammatory conditions.
CONDITIONS
Official Title
Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Families with at least one child or adult affected by inflammatory bowel disease (IBD) or juvenile idiopathic arthritis (JIA)
- Father and mother with children aged between 0 and 18 years, in good health
- At least one adult or child affected by IBD, or a child affected by JIA, regardless of therapy or disease severity
- Healthy families with father and mother and children aged 0 to 18 years, in good health and without chronic inflammatory or autoimmune diseases
You will not qualify if you...
- For subjects with IBD: monogenic disease
- For subjects with IBD: children with an ileostomy or who have undergone colectomy
- For healthy subjects: any chronic inflammatory bowel disease, autoimmune disease, or ongoing infectious disease
- No exclusion criteria for subjects with JIA
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
AOU Meyer IRCCS
Florence, Italy, Italy
Actively Recruiting
2
Università La Sapienza di Roma
Roma, Roma, Italy, 00185
Actively Recruiting
3
Università di Foggia
Foggia, Italy
Actively Recruiting
4
Ospedale Villa Sofia Cervello, Università di Palermo
Palermo, Italy
Actively Recruiting
Research Team
P
Paolo Lionetti, MD, PhD, Ordinary Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here